Pavion Blue Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Pavion Blue Capital's LLY Position: Q1 2026 in Review
Pavion Blue Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 1,805 shares worth $1.66M. The position accounts for 0.72% of the portfolio, ranked #37.
Pavion Blue Capital first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.66M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Pavion Blue Capital held 1,805 shares of Eli Lilly worth $1.66M as of Q1 2026.
- Pavion Blue Capital left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.72% of Pavion Blue Capital's portfolio in Q1 2026, its #37 holding.
- Pavion Blue Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- Pavion Blue Capital's Eli Lilly position peaked at $2.66M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.